A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

Study Identifier
206207-008
CT.gov Identifier
NCT00168324
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Macular Edema
    • Study Drug
  • 700 µg Dexamethasone
  • 350 µg Dexamethasone
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * 18 years of age or older with macular edema resulting from retinal vein occlusion * Decrease in visual acuity in at least one eye as a result of macular edema (20/50 or worse) * Visual acuity in other eye no worse than 20/200
    Exclusion Criteria:
    * Known anticipated need for ocular surgery within next 12 months * History of glaucoma or current high eye pressure requiring more than 1 medication * Diabetic retinopathy * Uncontrolled systemic disease * Known steroid-responder * Use of systemic steroids * Use of warfarin/heparin

    Protocol Summary

    This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of macular edema associated with retinal vein occlusion.

    Study Locations

    Location
    Status
    Location
    Los Angeles, California, United States
    Status
    Not applicable
    Location
    Sydney, Australia
    Status
    Not applicable
    Location
    Graz, Austria
    Status
    Not applicable
    Location
    Halifax, Nova Scotia, Canada
    Status
    Not applicable
    Location
    Brno, Czech Republic
    Status
    Not applicable
    Location
    Créteil, France
    Status
    Not applicable
    Showing {first} - {last} of {total} Results